RTX Stock Analysis: RTX | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 269.078m USD | 12M Return: 14.7% | US75513E1010 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.03B
EPS Trend: 98.9%
Qual. Beats: 12
Rev. Trend: 98.8%
Qual. Beats: 3
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
RTX Corporation is a major U.S.-based aerospace and defense company headquartered in Arlington, Virginia, operating through three core segments: Collins Aerospace, Pratt & Whitney, and Raytheon. The company provides systems, components, and services to commercial, military, and government customers worldwide. Collins Aerospace focuses on a broad range of aircraft systems and aftermarket support, Pratt & Whitney supplies engines and aftermarket services across aviation markets, and Raytheon delivers sensors, mission systems, and software for threat detection and mitigation. The company was originally incorporated in 1934 and adopted the RTX name in July 2023, following its prior identity as Raytheon Technologies Corporation.
Operating in the GICS Aerospace & Defense sub-industry, RTX benefits from long-cycle demand drivers such as global commercial aviation growth and rising defense budgets across the U.S. and allied nations. Its diversified business model spans both original equipment manufacturing (OEM) and high-margin aftermarket services, including maintenance, repair, overhaul (MRO), and fleet management, which typically provide recurring revenue and help offset the cyclicality of new aircraft and weapons platform orders.
- Pratt & Whitney GTF powder metal recall pressures margins and cash flow
- Raytheon missile defense backlog grows on elevated global defense spending
- Collins Aerospace aftermarket revenue scales with commercial aviation recovery
| Net Income: 8.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.27 > 1.0 |
| NWC/Revenue: 2.99% < 20% (prev 4.52%; Δ -1.53% < -1%) |
| CFO/TA 0.07 > 3% & CFO 12.4b > Net Income 8.53b |
| Net Debt (31.2b) to EBITDA (16.8b): 1.86 < 3 |
| Current Ratio: 1.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.37b) vs 12m ago 0.71% < -2% |
| Gross Margin: 21.10% > 18% (prev 20.13%; Δ 0.97% > 0.5%) |
| Asset Turnover: 55.60% > 50% (prev 50.98%; Δ 4.62% > 0%) |
| Interest Coverage Ratio: 7.84 > 6 (EBIT TTM 12.4b / Interest Expense TTM 1.58b) |
| A: 0.02 (Total Current Assets 66.1b - Total Current Liabilities 63.2b) / Total Assets 177b |
| B: 0.34 (Retained Earnings 60.6b / Total Assets 177b) |
| C: 0.07 (EBIT TTM 12.4b / Avg Total Assets 173b) |
| D: 0.66 (Book Value of Equity 69.2b / Total Liabilities 106b) |
| Altman-Z'' = 2.40 = BBB |
| DSRI: 0.45 (Receivables 14.7b/29.4b, Revenue 96.0b/86.0b) |
| GMI: 0.95 (GM 20.13% / 21.10%) |
| AQI: 0.94 (AQ_t 0.52 / AQ_t-1 0.55) |
| SGI: 1.12 (Revenue 96.0b / 86.0b) |
| TATA: -0.02 (NI 8.53b - CFO 12.4b) / TA 177b) |
| Beneish M = -3.48 (Cap -4..+1) = AA |
As of November 05, 2026, the stock is trading at USD 198.43 with a total of 7,134,969 shares traded. Over the past week, the price has changed by +1.32%, over one month by +7.65%, over three months by -8.65% and over the past year by +14.67%.
Current recommended Stop Loss: 186.80 (which is 5.9% or 2.5 ATR below the current price).
RTX has received a consensus analysts rating of 4.08. Therefore, it is recommended to buy RTX.
- StrongBuy: 10
- Buy: 6
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 229.2 | 15.5% |
P/E Trailing = 32.4228
P/E Forward = 25.0627
P/S = 2.8033
P/B = 3.8162
P/EG = 2.1405
Revenue TTM = 96.0b USD
EBIT TTM = 12.4b USD
EBITDA TTM = 16.8b USD
Long Term Debt = 31.5b USD (from longTermDebt, last quarter)
Short Term Debt = 5.89b USD (from shortTermDebt, last quarter)
Debt = 40.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.50b
Net Debt = 31.2b USD (calculated: Debt 40.4b - CCE 9.17b)
Enterprise Value = 300b USD (269b + Debt 40.4b - CCE 9.17b)
Interest Coverage Ratio = 7.84 (Ebit TTM 12.4b / Interest Expense TTM 1.58b)
EV/FCF = 32.90x (Enterprise Value 300b / FCF TTM 9.13b)
FCF Yield = 3.04% (FCF TTM 9.13b / Enterprise Value 300b)
FCF Margin = 9.51% (FCF TTM 9.13b / Revenue TTM 96.0b)
Net Margin = 8.88% (Net Income TTM 8.53b / Revenue TTM 96.0b)
Gross Margin = 21.10% ((Revenue TTM 96.0b - Cost of Revenue TTM 75.7b) / Revenue TTM)
Gross Margin QoQ = 23.25% (prev 20.77%)
Tobins Q-Ratio = 1.70 (Enterprise Value 300b / Total Assets 177b)
Interest Expense / Debt = 3.93% (Interest Expense 1.58b / Debt 40.4b)
Taxrate = 18.72% (2.03b / 10.9b)
NOPAT = 10.1b (EBIT 12.4b * (1 - 18.72%))
Current Ratio = 1.05 (Total Current Assets 66.1b / Total Current Liabilities 63.2b)
Debt / Equity = 0.58 (Debt 40.4b / totalStockholderEquity, last quarter 69.2b)
Debt / EBITDA = 1.86 (Net Debt 31.2b / EBITDA 16.8b)
Debt / FCF = 3.42 (Net Debt 31.2b / FCF TTM 9.13b)
Total Stockholder Equity = 66.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.94% (Net Income 8.53b / Total Assets 177b)
RoE = 12.77% (Net Income TTM 8.53b / Total Stockholder Equity 66.8b)
RoCE = 12.65% (EBIT 12.4b / Capital Employed (Equity 66.8b + L.T.Debt 31.5b))
RoIC = 8.83% (NOPAT 10.1b / Invested Capital 114b)
WACC = 6.19% (E(269b)/V(309b) * Re(6.64%) + D(40.4b)/V(309b) * Rd(3.93%) * (1-Tc(0.19)))
Discount Rate = 6.64% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 99.37 | Cagr: 0.86%
[DCF] Terminal Value 77.97% ; FCFF base≈7.43b ; Y1≈8.52b ; Y5≈12.5b
[DCF] Fair Price = 116.7 (EV 189b - Net Debt 31.2b = Equity 157b / Shares 1.35b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.85 | EPS CAGR: 14.12% | SUE: 4.0 | # QB: 12
Revenue Correlation: 98.80 | Revenue CAGR: 12.55% | SUE: 1.59 | # QB: 3
EPS current Quarter (2027-03-31): EPS=1.81 | Chg30d=+2.36% | Revisions=-25% | Analysts=9
EPS current Year (2026-12-31): EPS=7.65 | Chg30d=+5.60% | Revisions=+29% | GrowthEPS=+21.6% | GrowthRev=+9.9%
EPS next Year (2027-12-31): EPS=8.05 | Chg30d=+2.48% | Revisions=-22% | GrowthEPS=+5.2% | GrowthRev=+7.7%
[Analyst] Revisions Ratio: -7% (up=5, down=6)